Cardiovascular risk associated with celecoxib

N Engl J Med. 2005 Jun 23;352(25):2648-50; author reply 2648-50. doi: 10.1056/NEJM200506233522519.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Celecoxib
  • Cyclooxygenase Inhibitors / adverse effects*
  • Data Interpretation, Statistical
  • Humans
  • Lactones / adverse effects
  • Pyrazoles / adverse effects*
  • Risk
  • Sulfonamides / adverse effects*
  • Sulfones / adverse effects

Substances

  • Cyclooxygenase Inhibitors
  • Lactones
  • Pyrazoles
  • Sulfonamides
  • Sulfones
  • rofecoxib
  • Celecoxib